Risk Assessment Report – 27 april 2020
Risk Assessment Report – 27 april 2020
Rapid Risk Assessment
April 27, 2020
Risk Assessment Report – 27 april 2020
Time Period Covered April 27, 2020 - April 27, 2020
- World Health Organization (WHO), together with heads of state, global health leaders, private sector partners and other stakeholders launched the Access To COVID-19 Tools (ACT) Accelerator, a global collaboration to accelerate the development, production and equitable access to new COVID-19 diagnostics, therapeutics and vaccines.
- The provincial health Commission stated that no new confirmed cases of COVID-19 disease were reported in central China's Hubei Province as of April 27.
- Cambodia reports no new COVID-19 case/s since April 12.
- Laos reports no new COVID-19 case/s since April 12.
- Brunei reports no new COVID-19 case/s since April 19.
- On April 26, Thailand's Ramathibodi Hospital has learned tests on suspected persons’ saliva for the COVID-19 is as precise as tests using secretions from the nose or throat. According to Department of Disease Control, the new system of saliva test is being developed at the Bamrasnaradura Infectious Diseases Institute. The Public Health Ministry will use saliva tests for asymptomatic persons in slums and at border checkpoints. However, patients under investigation (PUI) will still have to undergo more detailed tests.
- On April 26, the Indonesian government’s COVID-19 Task Force received shipment of laboratory supplies and equipment from China on Saturday to help achieve a minimum testing number of 10,000 per day. These include viral ribonucleic acid (RNA) isolation kit, multiplex reverse transcription polymerase chain reaction (RT-PCR) machine and viral transport medium kit. These were immediately distributed to hardest-hit provinces including Jakarta, West Java, Central Java and East Java.
- Vietnam’s locally made test kit for COVID-19 has been approved by the World Health Organization (WHO) after enduring five rounds of testing and quality assessments. The quality of Vietnam’s test kits have been evaluated to be on par with that of WHO kit and the US Center for Disease Control and Prevention (CDC), but they also offer other advantages including their specificity, stability, and adaptability with multiple types of testing equipment.
Risk Assessment Report – 27 april 2020